TPD & Induced Proximity Summit Leaderboard
  • Wednesday, July 29, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 730

Author

Pharma Journalist 8962 posts 0 comments

CStone’s MEK Inhibitor CS3006 Receives IND Approval in China

Jul 31, 2018
CStone Pharmaceuticals (CStone) announced that its IND application for CS3006, a small-molecule inhibitor of mitogen-activated protein kinase (MEK), has been approved by the China…
Read More...

Lilly Announces Extension of Cancer Research Collaboration with Dana-Farber Cancer Institute

Jul 31, 2018
Eli Lilly and Company announced a three-year extension of its cancer research collaboration with Dana-Farber Cancer Institute. Since 2015, scientists from Lilly and Dana-Farber have…
Read More...

Imfinzi receives positive EU CHMP opinion for locally-advanced, unresectable non-small cell lung…

Jul 31, 2018
AstraZeneca and MedImmune, its global biologics research and development arm, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
Read More...

MilliporeSigma and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery…

Jul 30, 2018
MilliporeSigma and InnoCore Pharmaceuticals; Groningen, Netherlands, have entered into a global cooperation agreement to provide InnoCore’s proprietary SynBiosys biodegradable polymer…
Read More...

FDA Approves PERSERIS (risperidone) for Extended-Release Injectable Suspension for the Treatment of…

Jul 28, 2018
Indivior PLC (LON: INDV) today announced that the U.S. Food and Drug Administration (FDA) has approved PERSERISTM, the first once-monthly subcutaneous risperidone-containing,…
Read More...

MannKind and Tanner Pharma Group Enter into an ex-U.S. Distribution Agreement for Afrezza

Jul 28, 2018
MannKind Corporation, a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial…
Read More...

Genprex Enters Agreement with the University of Texas MD Anderson Cancer Center to Study Oncoprex in…

Jul 27, 2018
Genprex has entered a Sponsored Research Agreement with The University of Texas MD Anderson Cancer Center under which Genprex will sponsor a pre-clinical study, entitled “A Novel…
Read More...

KEYTRUDA (pembrolizumab) is the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma

Jul 27, 2018
Merck, known as MSD outside the United States and Canada, announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has been approved by the China National Drug Administration (CNDA) for the…
Read More...

PureTech Health Announces Collaboration with Roche to Advance Technology for Oral Administration of…

Jul 27, 2018
PureTech Health plc announced that it has entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., to advance PureTech’s milk-derived exosome…
Read More...

AbbVie Receives FDA Approval of ORILISSA for endometriosis pain

Jul 27, 2018
AbbVie in cooperation with Neurocrine Biosciences announced that the U.S. Food and Drug Administration (FDA) approved ORILISSA™ (elagolix), the first and only oral…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Bora to Manufacture GERD Drug for U.S. Phase 3 Trial
  • FDA Grants Fast Track Status to Lundbeck’s Narcolepsy Drug
  • Affinia Gene Therapy Wins FDA Orphan Drug Status for Rare Heart Disease
  • BeOne Invests $300 Million in U.S. Manufacturing Expansion
  • Kairos and Bayer Partner on Advanced Prostate Cancer Study

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.